Archive
e-therapeutics jumps as share overhang created by Woodford’s need to liquidate assets further cleared
A look at some of the biggest risers and fallers in London on Thursday
Company
Allergy Therapeutics PLC
LON:AGY
Allergy Therapeutics PLC is an international commercial biotechnology company, headquartered in the UK, focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The company sells proprietary and third-party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
298 stories · page 2 of 3
Allergy Therapeutics jumps as it lifts profit forecasts after multi-million-dollar legal victory
Tight cost control and solid sales growth means this year’s profits will be better than initially expected, while the company has also received US$7.6mln in compensation after a 2016 trial cock-up
Archive
Ted Baker tumbles to seven-year low as HSBC slashes target
A look at the day's major movers, including Ted Baker, IAG, easyJet, Bagir, Blue Prism, EVR, Blackbird, Nu-Oil & Gas, Anglo Asian Mining and Petrel Resources
Archive
Proactive news snapshot: Nu-Oil and Gas, Futura Medical, Anglo Asian Mining …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
FTSE 100 slips at close as investors brace for US Fed decision
All eyes will be on the statement from Fed rate setters later, especially due to the pressure to lower rates from President Trump
Archive
Proactive news snapshot: WYG, Echo Energy, Collagen Solutions. Bacanora Lithium …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Frontier Smart Technologies soars after rejecting bid approach from Science Group
A look at the day's major movers, including TLOU Energy, Ten Lifestyle, Katoro Gold, Equatorial Palm Oil, Volga Gas, WYG, AB Dynamics and LXI REIT.
Allergy Therapeutics reports positive results from early-stage study of dust mite jab
Not only was Acarovac seen to be safe and well-tolerated in the phase I trial, but the 16 patients taking part also enjoyed a “significant improvement” in their symptoms
Investments and investor services
FTSE 100 closes in the red as trade tensions and Brexit confusion rumble on
The UK index of leading shares closed down nearly 38 points at 7,310
Archive
Proactive news snapshot: Kromek, ITM Power, Rockfire Resources
A glance at some of the day's highlights from the Proactive Investors newswire
Allergy Therapeutics thinks its adjuvant system could be used in fight against cancer
The combination of Allergy’s Microcrystalline Tyrosine (MCT) adjuvant system with virus-like particles proved successful in mice
Archive
Proactive news snapshot: Feedback, BigDish, Scancell, Sirius Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Sirius Minerals blooms after signing agribusiness deal
A look at the day's major movers, including Image Scan, Water Intelligence, Laura Ashley, Gulf Marine, Synectics and Synnovia
Allergy Therapeutics gets regulatory green light for phase III grass pollen trial
The company is aiming for regulatory approvals in both the US and Europe
Archive
FTSE 100 ends lower as US stocks retreat after mixed tech earnings
The FTSE 100 index closed 37.62 points, or 0.5% lower at 7,434.13, albeit above the session low of 7,405.99 as US stocks continued to post big falls on Thursday
Archive
Proactive news snapshot: WideCells Group, Tlou Energy, Oriole Resources, Strategic Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Defenx on the back foot as it draws down last of its loan facility
A look at the day's major movers, including AssetCo, Restore, Miton, Maintel, Microsaic, Footasylum, TomCo, GoldStone and Bluebird
Allergy Therapeutics surprised by the results of PQ Birch jab trial
The B301 trial was a multi-centre, double-blind, placebo-controlled study designed to test the efficacy in birch-pollen induced seasonal allergic rhinitis
Investments and investor services
FTSE 100 closes higher as Bercow deals blow to May's Brexit plan
Bercow says the government can only bring back the vote if there has been substantial 'change' to the Brexit deal
Archive
Proactive news snapshot: 88 Energy, Allergy Therapeutics, VR Education …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
IWG shrugs off profit fall with upbeat outlook
A look at some of the biggest risers and fallers on the London stock market on Wednesday.
Allergy Therapeutics sees first-half sales, profits jump ahead of “pivotal” year
Allergy has a slew of data due to be published in the coming months, while key studies of its grass and peanut allergy jabs are due to kick off later in the year
Archive
FTSE 100 closes up while European indices fall despite talk of new ECB lending
Footsie closed at 7,196 - up 12.57 points, while FTSE 250 finished in the red - down around 83 at 198,359
Archive
Legal & General to see new chief exec hog spotlight on Wednesday
While the insurer is scheduled to report its finals, the figures may be overshadowed by the new head of its investment management arm Michelle Scrimgeor
Archive
Insurance will be the corporate key in coming week, though US jobs data should be biggest draw
The Week Ahead brings updates from the likes of Aviva, Direct Line, L&G and Admiral, while investors can also bet on Paddy Power Betfair and GVC Holdings
Archive
TechFinancials shares advance as it offloads struggling business
A look at some of the top risers and fallers in London on Wednesday
Archive
Proactive news snapshot: BigDish, Allergy Therapeutics, Cadogan Petroleum …
A glance at some of the day's highlights from the Proactive Investors newswire
Allergy Therapeutics higher as revenues rise 10.6%, cash reserves grow
The drug developer's trading statement revealed the latest numbers were in line with market forecasts
Archive
FTSE 100 closes lower amid more political noise; Pearson biggest laggard
The UK's blue-chip index closed down around 32 points at 6,862 on the day
Archive
Proactive news snapshot: Oriole Resources, OptiBiotix Health, Strategic Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
De La Rue, Walker Cripps shares moving lower
A look at some winners and losers in the UK equity market on Tuesday
Allergy Therapeutics says revenues “up strongly on prior year” in update ahead of AGM
The firm, which specialises in allergy vaccines, said sales were in line with expectations for the year, adding that it had continued to gain market share in Europe
Investments and investor services
FTSE 100 closes in the red as Brexit and trade worries dampen the mood
Footsie closed the day down around 19 points at 7,016, with big miners in the losers list.
Archive
Troubled retail sector in focus as Quiz, Topps Tiles and Pets at Home report latest results
The day ahead includes full year results from Topps Tiles and Pets at Home along with interims from Quiz and Pennon
Archive
Christmas lights starting to peek out from under spreadsheets as updates slow in last week of November
The Week Ahead will bring a hotch-potch of updates from the likes of blue-chip Intertek Group, and mid caps Thomas Cook, Pennon, Greene King, Go-Ahead Group, and Britvic
Investments and investor services
Wincanton on the right road as strong cash flow whittles away debt
A look at the day's poppers and droppers, including JD Wetherspoon, Gattaca, Renewi, AdEPT, The Works, Coca-Cola HBC and Micro Focus
Archive
Proactive news snapshot: Immotion Group, NetScientific, AdEPT Technology …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
FTSE 100 closes higher ahead of Federal Reserve meeting
The focus is now on the Federal Reserve meeting later. The interest rate announcement is set for 7.00pm, UK time
Archive
Proactive news snapshot: Amryt Pharma, Directa Plus, Live Company...
A glance at some of the day's highlights from the Proactive Investors newswire
Allergy Therapeutics pleased with the current momentum in the business
"We look forward to the exciting developments in our early pipeline planned for 2019, and we expect to continue to grow our European business while progressing towards US and German registration for our lead products," said company chairman
Investments and investor services
FTSE 100 closes near flat as traders sit on hands ahead of Fed
The UK blue-chip index closed nearly four points higher at 7,511
Archive
Expected US interest rate hike to draw the attention Wednesday, as Trump trade wars rumble on
Aside from the US interest rate decision, corporate updates are due from online fashion retailer Boohoo Group, outsourcer MITIE, and automotive services firm The AA ...
Archive
US interest rate hike eyed, as retailers, tour operators and utilities provide updates in coming week
Aside from the latest Federal Reserve policy meeting, the week ahead will bring updates from the likes of Next, Thomas Cook, TUI, United Utilities, and Pennon
Archive
Proactive news snapshot: dotdigital Group, Live Company Group, ECR Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Everyman's plans to open a cinema in the heart of the City welcomed by the City
Companies featured today: Babcock, Be Heard, dotdigital, Everyman, Goals Soccer Centres and Sopheon
Allergy Therapeutics raises £10.6mln to fund expansion of late-stage PQ Grass study
As well as funding the late-stage PQ Grass trial, the cash will also be used to part-fund the phase II study of Acarovac, the company’s dust mite allergy treatment
Investments and investor services
FTSE 100 closes marginally higher but European peers and US stocks lag
Footsie closed up around seven points, or 0.10% at 7,683 on Thursday
Bellzone knocks out £1mln placing after recent share price surge
Some of the main news-driven risers and fallers in London on Thursday ...
Archive
Proactive news snapshot: AFC Energy, ADES International, Europa Oil & Gas …
A glance at some of the day's highlights from the Proactive Investors newswire
Allergy Therapeutics full-year revenues to rise once again despite “unusually weak” pollen season
The allergy vaccines maker expects to report a 6.6% rise in revenues for the year ended June 30
FTSE 100 closes higher Thursday as traders come back to equities
Sterling was also stronger - up 0.06% to 1.1318 against the Euro and up 0.12% versus the US dollar
Archive
Proactive news snapshot: Greatland Gold, 88 Energy, MySQUAR, Galantas Gold …
A glance at some of the day's highlights from the Proactive Investors newswire
Edenville Energy shares up as it extends MoU with Chinese contractor for Rukwa project
A look at some of the top risers and fallers in London today
Allergy Therapeutics announces publication of positive data of Pollinex Quattro Grass vaccines
The company said each of the clinical symptoms (runny nose, sneezing and conjunctivitis) were statistically significantly reduced in treated patients compared with controls without allergen-specific immunotherapy
FTSE 100 crashes 2.26% as traders shun risk
FTSE 100 tanked on the day, along with other European indices
Archive
Proactive news snapshot: ImmuPharma, Advanced Oncotherapy, Mosman Oil And Gas …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
88 Energy surges after confirming it on track to restart well-testing at Icewine-2
A look at today's major risers and fallers in London, including Advanced Oncotherapy, Tekcapital, IDOX, RedstoneConnect, Dixons Carphone and Renold
Allergy Therapeutics announces positive new clinic data with house-dust mite immunotherapy
The AIM-listed biotechnology company said the total of 141 patients were evaluated and they demonstrated a 43% decrease in combined symptom medication score compared with baseline after one year
FTSE 100 drops 1.26% as political turmoil in Europe hits
In the current markets, the pound fell 0.49% against the US dollar at 1.1472..
VR Education zips higher as another director puts his money where his mouth is
Some of the main news-driven risers and fallers on Monday afternoon...
Archive
Proactive news snapshot: Proactive news snapshot: Allergy Therapeutics, Netscientific. Kibo Mining …
A glance at some of the day's highlights from the Proactive Investors newswire
Allergy Therapeutics readies grass pollen treatment for Phase III trial after “extremely positive” mid-stage results
The Phase II study of Allergy Therapeutics’ PQ Grass immunotherapy – an aluminium-free, ultra-short course hay fever treatment – evaluated dose response and safety
Investments and investor services
FTSE 100 propelled to new record close as pound weakens and Dow Jones breaches 25,000
FTSE 100 reached a new record close on Monday after achieving it last time on Thursday
Archive
Proactive news snapshot: HemoGenyx Pharmaceuticals, Harvest Minerals, Touchstone Exploration …
A glance at some of the day's highlights from the Proactive Investors newswire
MTI Wireless shares fall as it reports decrease in revenues and profit
A look at some of the top risers and fallers in London on Monday
Allergy Therapeutics highlights benefits of adjuvant technology in new paper
The study highlighted Allergy’s microcrystalline tyrosine (MCT) was a suitable and flexible alternative to aluminium hydroxide
FTSE 100 closes in red as there is little around to spark investor interest
FTSE 250 fared better though closing ahead by around 15 points at 20,800.
Archive
Proactive news snapshot: Instem, Harvest Minerals, MySQUAR …
A glance at some of the day's highlights from the Proactive Investors newswire
Volvere shares gain as it estimates record 2017 revenues
A look at some of the biggest risers and fallers in London on Wednesday
Allergy Therapeutics grows market share ahead of key trial results
Interim revenues at the hay fever vaccine specialist rose by 4% to £42.2mln
Investments and investor services
FTSE 100 closes in positive territory despite Trump trade war fears
Around 3.50pm, the FTSE 100 index was up 13 points at 7,160
Archive
Proactive news snapshot: Mosman Oil And Gas, Midatech Pharma, Thor Mining …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Defenx dented after downbeat trading update; is exploring funding options
Defenx is not the first software company to invoice customers only to see the orders delayed
Allergy Therapeutics teams up with German manufacturer to scale up production of peanut allergy vaccine
Chief executive Manuel Llobet said: "The disruption to patients' social and family life as a result of food allergies is significant, and we are committed to addressing these current unmet needs"
Investments and investor services
FTSE 100 closes firmly lower on chilly Wednesday with ITV the big switch-off
The Footsie may have mainly traded sideways throughout the day but there have been some notable movements among blue-chips.
Archive
Proactive news snapshot: Oracle Power, Anglo Asian Mining, 88 Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Allergy Therapeutics' grass pollen study running ahead of schedule
The Phase II study of its PQ Grass immunotherapy, an aluminium-free, ultra-short course hay fever treatment, is designed to evaluate dose response and safety
Investments and investor services
FTSE 100 heats up as defensives are given the cold shoulder
The index of blue-chip shares eased off a little in the final half-hour
Archive
Proactive news snapshot: Cradle Arc, Echo Energy, Satellite Solutions Worldwide …
A glance at some of the day's highlights from the Proactive Investors newswire
Investors hang up on TalkTalk as Exane slashes price target and forecasts another cut to the divi
Some of the main news-driven share price changes in London on Wednesday ...
Allergy Therapeutics expects first-half revenue rise; continues to take market share from rivals
The company has a portfolio of vaccines which treat the symptoms of various allergies, including dust mites, grass, pollen and venom
FTSE 100 ends lower as pound firms; housebuilders weigh
Britain's top tier index closed around 54 points lower at 7,533
Archive
Proactive news snapshot: Ortac Resources, Strategic Minerals, Scancell Holdings…
A glance at some of the day's highlights from the Proactive Investors newswire
Bioquell jumps as says expects 2017 earnings to be "significantly" ahead of market expectations
A look at some of the top risers and fallers in London today
Allergy Therapeutics completes recruitment for phase III birch pollen trial
Results from study of PQ Birch are expected in the second half of this year
FTSE 100 reaches new closing high with supermarkets in support
London's top tier index reached a new record high on Tuesday, led by supermarket shares
Archive
Proactive news snapshot: ValiRx, W Resources, Falcon Oil & Gas …
A glance at some of the day's highlights from the Proactive Investors newswire
Surprise trading update is just the job for Robert Walters
The trading update was short and sweet. Liberum responded by increasing its target price.
Allergy Therapeutics teams up with Ergomed to take its anti-allergy tablets through the clinic
Allergy already has injectable vaccines for dust mites and tree and grass pollen, but it has brought in Ergomed to take the tablet formulations through clinical trials
FTSE 100 closes higher as energy stocks provide a boost; supermarkets weigh
Robert Walters sprang a pleasant surprise on the market with an unscheduled trading update.
Anglesey Mining sees movement at Parys Mountain as base metal prices climb
A number of base metals contained within the deposit have risen sharply in price
Archive
Proactive news snapshot: Green Dragon Gas, Ergomed, IXICO …
A glance at some of the day's highlights from the Proactive Investors newswire
Petra Diamonds' shares sparkle after Tanzania lifts export ban
The government of Tanzania has given Petra the go-ahead to resume diamond exports and sales from the Williamson mine.
Allergy Therapeutics - strong financial showing, solid cash position, progress in the clinic
Allergy, which saw its market share grow by a percentage point to 13%, is in a strong financial position, with £22.1mln in the bank
FTSE 100 closes up but optimism not "particularly high"
FTSE 100 ended in positive territory, having been lower earlier,..
Investments and investor services
Eyes on TUI as it reveals first half results on Thursday
TUI already tipped off the market that it enjoyed a strong second quarter performance.
Archive
Focus on tour operators TUI and Thomas Cook and utilities in week ahead
Week ahead includes trading updates from tour operators TUI AG and Thomas Cook Group PLC, and numbers from Pennon Group PLC and United Utilities PLC